MENU
PTHS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Pelthos Therapeutics (PTHS) Ownership - Who owns Pelthos Therapeutics?
Pelthos Therapeutics Inc is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.27M
P/E Ratio
N/A
Total Cash
131.32K
Projected Growth
N/A
Total Debt
2.5M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.20
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PTHS
Capitalization
14.3M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
131K
Total Cash/Share
0.20
Total Debt
2.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-4.2M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
621
Current Ratio
0.18
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-7.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-297.84
Shares Held By Institutions
855K
Shares Outstanding - Current
649K
Total Liabilities
5.11M
Total Volume MTD
N/A
Value
-1
Gain YTD
243.214
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information